Optimising scale-up of injectable lenacapavir for HIV pre-exposure prophylaxis in South Africa: A modelling study and economic evaluation.
August 01, 2026 | MedPage Today
BACKGROUND: South Africa accounts for 20% of global HIV infections. Six-monthly injectable...


Another HIV treatment option – but with less weight gain – Africa Health Research Institute
July 31, 2026 | The Kimberly Prospector
Read more: Another HIV treatment option – but with less weight gain – Africa Health Resear...


South Africa Study: Doravirine Cuts HIV Weight Gain
July 31, 2026 | ImNews Africa
New HIV Treatment Shows Promise in Reducing Weight Gain DATELINE: Johannesburg, South Afri...


Lenacapavir made up 1% of U.S. PrEP use in the first six months of 2025, study finds | AIDS 2026
July 31, 2026 | Managed Healthcare Executive
It is not surprising that it is taking some time for injectable lenacapavir for PrEP to ca...


S-löftet: Fem miljoner till ökade insatser för en trygg ålderdom med hiv
July 31, 2026 | Cision [SE]
Socialdemokraterna i Region Stockholm vill avsätta fem miljoner för att förbättra vården f...


Gut Metabolite Boosts HIV Treatment in Preclinical Study
July 31, 2026 | Technology Networks
A natural gut molecule repaired HIV-related damage and improved therapy....


De levde hårt, älskade stort – och dog i aids
July 31, 2026 | Expressen
...


Wealth inequality driving HIV and other pandemics, researchers say
July 31, 2026 | EurActiv
European donors have reduced development and health budgets in recent years HIV laborator...


Study finds 60% of HIV patients face delayed diagnosis
July 31, 2026 | The Economic Times
Published in the Journal of the Indian Medical Association in May, the study analysed 402 ...


How an Andhra doctor’s research could turn a Rs 50 skin test into a lifesaving tool for HIV-TB patients
July 31, 2026 | South First
The paper also stresses that the Mantoux test is not a substitute for CD4 counts or HIV vi...